Reported Q: Q2 2025 Rev YoY: +104.3% EPS YoY: +333.5% Move: +0.03%
Innovative Solutions and
ISSC
$19.90 0.03%
Exchange NASDAQ Sector Industrials Industry Aerospace Defense
Q2 2025
Published: May 15, 2025

Company Status Snapshot

Fast view of the latest quarter outcome for ISSC

Reported

Report Date

May 15, 2025

Quarter Q2 2025

Revenue

21.94M

YoY: +104.3%

EPS

0.30

YoY: +333.5%

Market Move

+0.03%

Previous quarter: Q1 2025

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $21.94M up 104.3% year-over-year
  • EPS of $0.30 increased by 333.5% from previous year
  • Gross margin of 51.4%
  • Net income of 5.34M
  • "We don't anticipate further delays post transition. There’s a lot of moving parts with the Honeywell transition, supply chain issues with delivering quantities to Lockheed, and we’re working closely with their teams to make this a successful transition. In terms of guidance, we’re well into over 30% growth as we see it." - Shahram Askarpour
ISSC
Company ISSC

Executive Summary

ISSC reported robust topline growth in Q2 2025, underscored by the Honeywell military product line contribution and stronger air transport/aftermarket demand. Revenue nearly doubled to $21.94 million from $10.74 million a year ago, delivering a YoY growth rate of approximately 104% and QoQ expansion of about 37%. The company achieved an EBITDA of $6.98 million and net income of $5.34 million, translating to an EBITDA margin of ~31.8% and a net income margin of ~24.3% for the quarter, supported by favorable product mix and operating leverage from military revenues. Management reiterated the strategic objective to derive at least 40% of revenue from military customers in fiscal 2025 and highlighted ongoing investments in the Exton, PA facility expansion, ERP/IT enhancements, and the integration of the Honeywell acquisition as key enablers of scalable growth.

However, ISSC’s profitability remains sensitive to mix-driven gross margin volatility and integration costs associated with acquisitions. Gross margin was 51.4% in Q2 2025—slightly down from 52.0% a year earlier but up from 41.4% in Q1 2025—reflecting the stabilization of margins on Honeywell products despite anticipated near-term lumpiness as manufacturing shifts consolidate. Free cash flow remained negative at -$0.27 million in the quarter mainly due to capex related to the Exton facility expansion and elevated working capital associated with higher revenue. The balance sheet shows solid liquidity with cash of $1.23 million at quarter end and $8.8 million of available financing capacity, while total debt stands at $27.40 million and net debt ~ $26.18 million, producing a leverage ratio around 1.4x. Management signaled expectations for continued revenue and EBITDA expansion, supported by a backlog of roughly $80 million and a strategic mix tilt toward defense programs.

In sum, ISSC is transitioning from a growth-by-acquisition phase to a scale-driven, high-EBITDA model anchored by a U.S.-based, vertically integrated production footprint. The near-term catalysts include successful Honeywell integration, completion of the Exton expansion by mid-2025, and ongoing military program wins, with the overarching risk that margin volatility and transition-related costs could temper quarterly performance. Investors should monitor: (1) execution of the Honeywell transition and supplier readiness, (2) the ramp of the Exton facility and utilization, (3) the military mix stability toward the 40% target, and (4) working capital dynamics and capex trajectory into fiscal 2026.

Key Performance Indicators

Revenue
Increasing
21.94M
QoQ: 37.37% | YoY: 104.26%
Gross Profit
Increasing
11.27M
51.36% margin
QoQ: 70.45% | YoY: 101.84%
Operating Income
Increasing
6.98M
QoQ: 419.74% | YoY: 325.08%
Net Income
Increasing
5.34M
QoQ: 624.86% | YoY: 341.63%
EPS
Increasing
0.30
QoQ: 614.29% | YoY: 333.53%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 21.94 0.30 +104.3% View
Q1 2025 15.97 0.04 +71.6% View
Q4 2024 15.38 0.18 +18.4% View
Q3 2024 11.77 0.09 +47.8% View
Q2 2024 10.74 0.07 +46.3% View